Publicaciones en colaboración con investigadores/as de University of Florence (103)

2024

  1. AI is a viable alternative to high throughput screening: a 318-target study

    Scientific Reports, Vol. 14, Núm. 1

  2. Clinical-Hematological Changes and Predictors of Severity in Acute Food Protein–Induced Enterocolitis Syndrome Reactions at Oral Food Challenge: A Multicenter Observational Study

    Journal of Allergy and Clinical Immunology: In Practice, Vol. 12, Núm. 9, pp. 2454-2467.e8

  3. Correction to: AI is a viable alternative to high throughput screening: a 318-target study (Scientific Reports, (2024), 14, 1, (7526), 10.1038/s41598-024-54655-z)

    Scientific Reports

  4. Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma.

    New England Journal of Medicine, Vol. 390, Núm. 4, pp. 301-313

  5. Forging academic excellence: crafting an open academic curriculum for European Urologists

    BJU International

  6. Global Framework for Scientific Event: A 32-Country & 118-Expert Collaborative Effort

    Barw Medical Journal, Vol. 2, Núm. 3, pp. 29-39

  7. The Comet Assay as a Tool in Human Biomonitoring Studies of Environmental and Occupational Exposure to Chemicals—A Systematic Scoping Review

    Toxics, Vol. 12, Núm. 4

  8. Whole Exome Sequencing Identifies Epithelial and Immune Dysfunction-Related Biomarkers in Food Protein-Induced Enterocolitis Syndrome

    Clinical and Experimental Allergy

2023

  1. Benign descriptors and ADNEX in two-step strategy to estimate risk of malignancy in ovarian tumors: retrospective validation in IOTA5 multicenter cohort

    Ultrasound in Obstetrics and Gynecology, Vol. 61, Núm. 2, pp. 231-242

  2. Co-occurrence of mutations in NF1 and other susceptibility genes in pheochromocytoma and paraganglioma

    Frontiers in Endocrinology, Vol. 13

  3. Combined Inhibition of Smoothened and the DNA Damage Checkpoint WEE1 Exerts Antitumor Activity in Cholangiocarcinoma

    Molecular cancer therapeutics, Vol. 22, Núm. 3, pp. 343-356

  4. Correction: “The 5th edition of The World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms” Leukemia. 2022 Jul;36(7):1720–1748 (Leukemia, (2022), 36, 7, (1720-1748), 10.1038/s41375-022-01620-2)

    Leukemia

  5. DNA strand break levels in cryopreserved mononuclear blood cell lines measured by the alkaline comet assay: results from the hCOMET ring trial

    Mutagenesis, Vol. 38, Núm. 5, pp. 273-282

  6. Envisaging a global infrastructure to exploit the potential of digitised collections

    Biodiversity Data Journal, Vol. 11

  7. External Validation of the Ovarian-Adnexal Reporting and Data System (O-RADS) Lexicon and the International Ovarian Tumor Analysis 2-Step Strategy to Stratify Ovarian Tumors into O-RADS Risk Groups

    JAMA Oncology, Vol. 9, Núm. 2, pp. 225-233

  8. Genomic and immune landscape Of metastatic pheochromocytoma and paraganglioma

    Nature Communications, Vol. 14, Núm. 1

  9. Inter-laboratory variation in measurement of DNA damage by the alkaline comet assay in the hCOMET ring trial

    Mutagenesis, Vol. 38, Núm. 5, pp. 283-294

  10. Long-term cryopreservation of potassium bromate positive assay controls for measurement of oxidatively damaged DNA by the Fpg-modified comet assay: results from the hCOMET ring trial

    Mutagenesis, Vol. 38, Núm. 5, pp. 264-272

  11. Measuring DNA modifications with the comet assay: a compendium of protocols

    Nature Protocols, Vol. 18, Núm. 3, pp. 929-989

  12. Selenium-analogs based on natural sources as cancer-associated carbonic anhydrase isoforms IX and XII inhibitors

    Journal of Enzyme Inhibition and Medicinal Chemistry, Vol. 38, Núm. 1